A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the year. Demand for the drugmaker’s Paxlovid treatment spurred by the ...

(Reuters) -Pfizer CEO Albert Bourla, under pressure from activist hedge fund Starboard Value, made his case to Wall Street on Tuesday that the drugmaker's turnaround is succeeding after it ...

Pfizer, facing down a contentious challenge from an activist investor, reported earnings for the third quarter Tuesday that handily beat Wall Street forecasts and led it to boost revenue guidance for ...

Are you a print subscriber? Activate your account. By Tim Nudd - 1 hour 14 min ago By Adrianne Pasquarelli - 5 hours 42 min ago By Erika Wheless - 5 hours 42 min ago By Brian Bonilla - 5 hours 42 ...

There's no guidance on drinking alcohol before getting a COVID booster or vaccine. Research on the Moderna or Pfizer-BioNTech vaccines did not ask trial participants to avoid alcohol. Research on ...

The United States on Monday said it was "deeply concerned" about a bill under consideration in Israel's parliament aimed at banning the UN's Palestinian refugee agency. "We have made quite clear ...

When scheduling an appointment on CVS.com, patients will be asked ... be able to schedule an appointment for a Moderna or Pfizer-BioNTech booster dose if they have had two previous doses with ...

When a novel coronavirus struck in early 2020, Pfizer’sPFE-1.18%decrease; red down pointing triangle chief executive, Dr. Albert Bourla, saw an opportunity to help save the world. He pushed the ...

America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David Joyner replacing Karen Lynch. CVS also withdrew its 2024 profit ...